Over-expression of Novel Proteins in Maize

  • Elizabeth E. HoodEmail author
  • John A. Howard
Part of the Biotechnology in Agriculture and Forestry book series (AGRICULTURE, volume 63)

One of the newest applications for over-expressed proteins in plants, including corn, is as a bio-factory for the production of vaccines, pharmaceuticals and industrial enzymes (Howard and Hood 2005). For these applications, many of the basic molecular and cellular techniques that are useful to study input traits can be applied to boost protein accumulation for the most cost-effective production model. This chapter focuses on this bio-factory application of proteins in maize.


Transgenic Plant Foreign Protein Transgenic Maize Corn Seed Molecular Farming 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Beach L, Tarczynski MC (2000) Methods of increasing accumulation of essential amino acids in seeds. US Patent 6,127,600, 3 October 2000Google Scholar
  2. Beach L, Orman B, Townsend J, Thomas L (1998) Reduction of endogenous seed protein levels in plants. US Patent 5,850,024, 15 December 1998Google Scholar
  3. Bednarek SY, Raikhel NV (1992) Intracellular trafficking of secretory proteins. Plant Mol Biol 20:133–150PubMedCrossRefGoogle Scholar
  4. Benfey PN, Chua N-H (1990 ) The cauliflower mosaic virus 35S promoter: combinatorial regulation of transcription in plants. Science 16:959–966CrossRefGoogle Scholar
  5. Biswas GCG, Ransoma C, Sticklen M (2006) Expression of biologically active Acidothermus cellulolyticus endoglucanase in transgenic maize plants. Plant Sci 171:617–623CrossRefGoogle Scholar
  6. Buchner J (2002) Introduction: the cellular protein folding machinery. Cell Mol Life Sci 59:1587– 1588PubMedCrossRefGoogle Scholar
  7. Caimi PG, McCole LM, Klein TM, Kerr PS (1996) Fructan accumulation and sucrose metabolism in transgenic maize endosperm expressing a Bacillus amyloliquefaciens SacB gene. Plant Physiol 110:355–363PubMedGoogle Scholar
  8. Chikwamba R, Cunnick J, Hathaway D, McMurray J, Mason H, Wang K (2002) A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Res 11:479–493PubMedCrossRefGoogle Scholar
  9. Clough RC, Pappu K, Thompson K, Beifuss K, Lane J, Delaney DE, Harkey R, Drees C, Howard JA, Hood EE (2006) Manganese peroxidase from the white-rot fungus Phanerochaete chrysosporium is enzymatically active and accumulates to high levels in transgenic maize seed. Plant Biotechnol J 4:53–62PubMedCrossRefGoogle Scholar
  10. Cordero MJ, Ravento's D, San Segundo B (1994) Expression of a maize proteinase inhibitor gene is induced in response to wounding and fungal infection: systemic wound-response of a monocot gene. Plant J 6:141–150PubMedCrossRefGoogle Scholar
  11. Daniell H, Streatfield SJ, Wycoff K (2001) Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci 6:219–226PubMedCrossRefGoogle Scholar
  12. Delaney D, Jilka J, Barker D, Irwin P, Poage M, Woodard S, Horn M, Vinas A, Beifuss K, Barker M, Wiggins B, Drees C, Harkey R, Nikolov Z, Hood E, Howard J (2003) Production of aprotinin in transgenic maize seeds for the pharmaceutical and cell culture markets. In: Vasil IK (ed) Proc 10th IAPTC&B Congress. Kluwer, Dordrecht, pp 393–394Google Scholar
  13. Doran PM (2006) Foreign protein degradation and instability in plants and plant tissue cultures. Trends Biotechnol 24:426–432PubMedCrossRefGoogle Scholar
  14. Fischer R, Twyman RM, Schillberg S (2003) Production of antibodies in plants and their use for global health. Vaccine 21:820–825PubMedCrossRefGoogle Scholar
  15. Fischer R, Stoger E, Schillberg S, Christou P, Twyman RM (2004) Plant-based production of bio-pharmaceuticals. Curr Opin Plant Biol 7:152–158PubMedCrossRefGoogle Scholar
  16. Gu Z, Glatz CE (2007) Recovery of recombinant dog gastric lipase from corn endosperm extract separation. Sci Technol 42:1195–1213Google Scholar
  17. Halim AH, Mitchell HL, Wassom CE (1973) Trypsin inhibitors of corn (Zea mays). Trans Kans Acad Sci 76:289–293PubMedCrossRefGoogle Scholar
  18. Hood E (2004) Bioindustrial and biopharmaceutical products from plants: In Proceedings of the 4th international crop science congress: new directions for a diverse planet, Brisbane.
  19. Hood EE, Woodard S (2002) Industrial proteins produced from plants. In: Hood EE and Howard JA (eds) Plants as factories for protein production. Kluwer, Dordrecht, pp 119– 135Google Scholar
  20. Hood EE, Woodard SL (2005) Commercialization of a protein product from transgenic maize. Natl Agric Biotechnol Council 17:147–157Google Scholar
  21. Hood EE, Witcher DR, Maddock S, Meyer T, Baszczynski C, Bailey MR, Flynn P, Register J, Marshall L, Bond D, Kulisek E, Kusnadi A, Evangelista R, Nikolov Z, Wooge C, Mehigh RJ, Hernan R, Kappel WK, Ritland D, Li C-P, Howard JA (1997) Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Mol Breed 3(4):291–306CrossRefGoogle Scholar
  22. Hood EE, Howard JA, Delaney DE (2002a) Method of increasing heterologous protein expression in plants. US Patent application 10/252732Google Scholar
  23. Hood EE, Woodard SL, Horn ME (2002b) Monoclonal antibody manufacturing in transgenic plants - myths and realities. Curr Opin Biotechnol 13:630–635CrossRefGoogle Scholar
  24. Hood EE, Bailey MR, Beifuss K, Magallanes-Lundback M, Horn ME, Callaway E, Drees C, Delaney DE, Clough R, Howard JA (2003) Criteria for high-level expression of a fungal laccase gene in transgenic maize. Plant Biotechnol J 1:129–140PubMedCrossRefGoogle Scholar
  25. Hood EE, Love R, Lane J, Bray J, Clough R, Pappu K, Drees C, Hood KR, Yoon S, Ahmad A, Howard JA (2007) Subcellular targeting is a key condition for high-level accumulation of cellulase protein in transgenic maize seed. Plant Biotechnol J 5(6):709– 719PubMedCrossRefGoogle Scholar
  26. Horn ME (2002) Expression of an SIV protein in transgenic maize for use as an edible vaccine and reagent supply. In: McElrath MJ, et al. (eds) Proc Keystone Symp, HIV-1 protection and control by vaccination (X8), 5–11 April, ColoradoGoogle Scholar
  27. Horn ME, Woodard SL, Howard JA (2004) Plant molecular farming: systems and products. Plant Cell Rep 22:711–720PubMedCrossRefGoogle Scholar
  28. Howard JA, Donnelly KC (2004) A quantitative safety assessment model for transgenic protein products produced in agricultural crops. J Agric Environ Ethics 17:545–558CrossRefGoogle Scholar
  29. Howard JA, Hood EE (2005) Bioindustrial and biopharmaceutical products produced in plants. In: Sparks D (ed) Advances in agronomy, vol 85. Academic, San Diego, pp 91– 124Google Scholar
  30. Howard JA, Hood EE (2007) Methods for growing nonfood products in transgenic plants. Crop Sci 47:1255–1262Google Scholar
  31. Jepson I, Martinez A, Sweetman JP (1999) Chemical-inducible gene expression systems for plants - a review. Pesticide Sci 54:360–367CrossRefGoogle Scholar
  32. Király O, Guan L, Szepessy E, Tóth M, Kukor Z, Sahin-Tóth M (2006) Expression of human cationic trypsinogen with an authentic N terminus using intein-mediated splicing in aminopeptidase P (pepP) deficient Escherichia coli. Protein Expr Purif 48:104–111PubMedCrossRefGoogle Scholar
  33. Kusnadi AR, Evangelista RL, Hood EE, Howard JA, Nikolov ZL (1998a) Processing of transgenic corn seed and its effect on the recovery of recombinant beta-glucuronidase. Biotechnol Bioeng 60:44–52CrossRefGoogle Scholar
  34. Kusnadi AR, Hood EE, Witcher DR, Howard JA, Nikolov ZL (1998b) Production and purification of two recombinant proteins from transgenic corn. Biotechnol Prog 14:149– 155CrossRefGoogle Scholar
  35. Lamphear BJ, Streatfield SJ, Jilka JM, Brooks CA, Barker DK, Turner DD, Delaney DE, Garcia M, Wiggins B, Woodard SL, Hood EE, Tizard IR, Lawhorn B, Howard JA (2002) Delivery of subunit vaccines in maize seed. J Control Release 85:169–180PubMedCrossRefGoogle Scholar
  36. Lamphear BJ, Barker DK, Brooks CA, Delaney DE, Lane JR, Beifuss K, Love R, Thompson K, Mayor J, Clough R, Harkey R, Poage M, Drees C, Horn ME, Streatfield SJ, Nikolov Z, Woodard SL, Hood EE, Jilka JM, Howard JA (2005) Expression of the sweet protein brazzein in maize for production of a new commercial sweetener. Plant Biotechnol J 3:103– 114PubMedCrossRefGoogle Scholar
  37. Ludwig DL, Witte L, Hicklin DJ, Prewett M, Bassi R, Burtrum D, Pereira DS, Jimenez X, Fox F, Saxena B, Zhou Q, Ma Y, Kang X, Patel D, Barry M, Kussie P, Zhu Z, Russell DA, Petersen WL, Jury TP, Gaitan-Gaitan F, Moran DL, Delannay X, Storrs BS, Tou J, Zupec ME, Gustafson KS, McIntyre J, Tarnowski SJ, Bohlen P (2004) Conservation of receptor antagonist anti-tumor activity by epidermal growth factor receptor antibody expressed in transgenic corn seed. Human Antibodies 13:81–90PubMedGoogle Scholar
  38. Ma JK, Barros E, Bock R, Christou P, Dale PJ, Dix PJ, Fischer R, Irwin J, Mahoney R, Pezzotti M, Schillberg S, Sparrow P, Stoger E, Twyman RM (2005) Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants. EMBO Rep 6:593–599PubMedCrossRefGoogle Scholar
  39. Marrs KA, Casey ES, Capitant SA, Bouchard RA, Dietrich PS, Mettler IJ, Sinibaldi RM (1993) Characterization of two maize HSP90 heat shock protein genes: expression during heat shock, embryogenesis, and pollen development. Dev Genet 14:27–41PubMedCrossRefGoogle Scholar
  40. Matsuoka M, Tada Y, Fujimura T, Kano-Murakami Y (1993) Tissue-specific light-regulated expression directed by the promoter of a C4 gene, maize pyruvate, orthophosphate dikinase, in a C3 plant, rice. Proc Natl Acad Sci USA 90:9586–9590PubMedCrossRefGoogle Scholar
  41. Matzke MA, Matzke A (1995) How and why do plants inactivate homologous (trans)genes? Plant Physiol 107:679–685PubMedGoogle Scholar
  42. Miles S, Arellano S, Krebs H, Nelson A, Batie C, Betts S (2007) Requirement of an ER-directed signal peptide for accumulation of active Trichoderma reesei cellobiohydrolase I in transgenic corn seed. In: Proc Plant Molecular Biology Retreat, 28–30 Sept. ASPB, ChicagoGoogle Scholar
  43. Peach C, Velten J (1991) Transgene expression variability (position effect) of CAT and GUS reporter genes driven by linked divergent T-DNA promoters. Plant Mol Biol 17:49–60PubMedCrossRefGoogle Scholar
  44. Rayon C, Lerouge P, Faye L (1998) The protein N-glycosylation in plants. J Exp Bot 49:1463– 1472CrossRefGoogle Scholar
  45. Russell DA, Fromm ME (1997) Tissue-specific expression in transgenic maize of four endosperm promoters from maize and rice. Transgenic Res 6:157–168PubMedCrossRefGoogle Scholar
  46. Samyn-Petit B, Gruber V, Flahaut C, Wajda-Dubos JP, Farrer S, Pons A, Desmaizieres G, Slomianny MC, Theisen M, Delannoy P (2001) N-glycosylation potential of maize: the human lactoferrin used as a model. Glycoconj J 18:519–527PubMedCrossRefGoogle Scholar
  47. Samyn-Petit B, Wajda Dubos JP, Chirat F, Coddeville B, Demaizieres G, Farrer S, Slomianny MC, Theisen M, Delannoy P (2003) Comparative analysis of the site-specific N-glycosylation of human lactoferrin produced in maize and tobacco plants. Eur J Biochem 270:3235–3242PubMedCrossRefGoogle Scholar
  48. Schöffl F, Schröder G, Kliem M, Rieping M (1993) An SAR sequence containing 395 bp DNA fragment mediates enhanced, gene-dosage-correlated expression of a chimaeric heat shock gene in transgenic tobacco plants. Transgenic Res 2:93–100PubMedCrossRefGoogle Scholar
  49. Sticklen M (2006) Plant genetic engineering to improve biomass characteristics for biofuels. Curr Opin Biotechnol 17:315–319PubMedCrossRefGoogle Scholar
  50. Stoger E, Sack M, Fischer R, Christou P (2002) Plantibodies: applications, advantages and bottlenecks. Curr Opin Biotechnol 13:161–166PubMedCrossRefGoogle Scholar
  51. Stoger E, Schillberg S, Twyman RM, Fischer R, Christou P (2004) Antibody production in transgenic plants. Methods Mol Biol 248:301–318PubMedGoogle Scholar
  52. Streatfield SJ (2005) Oral hepatitis B vaccine candidates produced and delivered in plant material. Immunol Cell Biol 83:257–262PubMedCrossRefGoogle Scholar
  53. Streatfield SJ (2007) Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol J 5:2–15PubMedCrossRefGoogle Scholar
  54. Streatfield SJ, Howard JA (2003) Plant-based vaccines. Int J Parasitol 33:479–493PubMedCrossRefGoogle Scholar
  55. Streatfield SJ, Jilka JM, Hood EE, Turner DD, Bailey MR, Mayor JM, Woodard SL, Beifuss KK, Horn ME, Delaney DE, Tizard IR, Howard JA (2001) Plant-based vaccines: unique advantages. Vaccine 19:2742–2748PubMedCrossRefGoogle Scholar
  56. Streatfield SJ, Mayor JM, Barker DK, Brooks C, Lamphear BJ, Woodard SL, Beifuss KK, Vicuna D, Massey L-A, Horn ME, Delaney DE, Nikolov ZL, Hood EE, Jilka JM, Howard JA (2002) Development of an edible subunit vaccine in corn against enterotoxigenic strains of Escherichia coli. In Vitro Cell Dev Biol Plant 38:11–17CrossRefGoogle Scholar
  57. Streatfield SJ, Lane JR, Brooks CA, Barker DK, Poage ML, Mayor JM, Lamphear BJ, Drees CF, Jilka JM, Hood EE, Howard JA (2003) Corn as a production system for human and animal vaccines. Vaccine 21:812–815PubMedCrossRefGoogle Scholar
  58. Streatfield SJ, Magallanes-Lundback ME, Beifuss KK, Brooks CA, Harkey RL, Love RT, Bray J, Howard JA, Jilka JM, Hood EE (2004) Analysis of the maize polyubiquitin-1 promoter heat shock elements and generation of promoter variants with modified expression characteristics. Transgenic Res 13:299–312PubMedCrossRefGoogle Scholar
  59. Streatfield SJ, Love RT, Bray J (2006) Globulin 2 regulatory region and method of using same. US Patent 7,112,723, 26 September 2006Google Scholar
  60. Streatfield SJ, Love RT, Bray J (2007a) Embryo preferred promoter and method of using same. US Patent 7,183,109, 27 February 2007Google Scholar
  61. Streatfield SJ, Love RT, Bray J (2007b) Globulin-1 regulatory region and method of using same. US Patent 7,169,967, 30 January 2007Google Scholar
  62. Torney F, Moeller L, Scarpa A, Wang K (2007) Genetic engineering approaches to improve bioethanol production from maize. Curr Opin Biotechnol 18:193–199PubMedCrossRefGoogle Scholar
  63. Twyman RM, Stoger E, Schillberg S, Christou P, Fischer R (2003) Molecular farming in plants: host systems and expression technology. Trends Biotechnol 21:570–578PubMedCrossRefGoogle Scholar
  64. Twyman RM, Schillberg S, Fischer R (2005) Transgenic plants in the biopharmaceutical market. Expert Opin Emerg Drugs 10:185–218PubMedCrossRefGoogle Scholar
  65. Watson ME (1984) Compilation of published signal sequences. Nucleic Acids Res 12:5145–5164PubMedCrossRefGoogle Scholar
  66. Watson SA (1988) Corn marketing, processing and utilization. In: Sprague GF, Dudley JW (eds) Corn and corn improvement, 3rd edn, vol 18. American Society of Agronomy, Crop Science Society of America, Soil Science Society of America, Madison, pp 885–942Google Scholar
  67. Whaley KJ, Zeitlin L (2000) Transgenic commensals as mucosal protectants. Nat Biotechnol 18:1038–1039PubMedCrossRefGoogle Scholar
  68. Witcher DR, Hood EE, Peterson D, Bailey M, Bond D, Kusnadi A, Evangelista R, Nikolov Z, Wooge C, Mehigh R, Kappel W, Register I, James C, Howard JA (1998) Commercial production of β-glucuronidase (GUS): a model system for the production of proteins in plants. Mol Breed 4:301–312CrossRefGoogle Scholar
  69. Woodard SL, Mayor JM, Bailey MR, Barker DK, Love RT, Lane JR, Delaney DE, McComas-Wagner JM, Mallubhotla HD, Hood EE, Dangott LJ, Tichy SE, Howard JA (2003) Maize (Zea mays)-derived bovine trypsin: characterization of the first large-scale, commercial protein product from transgenic plants. Biotechnol Appl Biochem 38:123–130PubMedCrossRefGoogle Scholar
  70. Zhong GY, Peterson D, Delaney DE, Bailey MR, Witcher DR, Register III JC, Bond D, Li C-P, Marshall L, Kulisek E, Ritland D, Meyer T, Hood EE, Howard JA (1999) Commercial production of aprotinin in transgenic maize seeds. Mol Breed 5:345–356CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, B.V 2009

Authors and Affiliations

  1. 1.Arkansas State UniversityUSA
  2. 2.Applied Biotechnology Institute, Building 36Cal Poly State UniversityUSA

Personalised recommendations